DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Patil VM, Noronha V, Joshi A, Choughule AB, Bhattacharjee A, Kumar R. et al.
Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma.
ESMO Open 2017;
2: e000168
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.